214 related articles for article (PubMed ID: 34907588)
41. Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.
Gini A; Jansen EEL; Zielonke N; Meester RGS; Senore C; Anttila A; Segnan N; Mlakar DN; de Koning HJ; Lansdorp-Vogelaar I;
Eur J Cancer; 2020 Mar; 127():224-235. PubMed ID: 31932176
[TBL] [Abstract][Full Text] [Related]
42. Colorectal Cancer Screening Programs in Latin America: A Systematic Review and Meta-Analysis.
Montalvan-Sanchez EE; Norwood DA; Dougherty M; Beas R; Guranizo-Ortiz M; Ramirez-Rojas M; Morgan DR; Imperiale TF
JAMA Netw Open; 2024 Feb; 7(2):e2354256. PubMed ID: 38300621
[TBL] [Abstract][Full Text] [Related]
43. Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations.
Bénard F; Barkun AN; Martel M; von Renteln D
World J Gastroenterol; 2018 Jan; 24(1):124-138. PubMed ID: 29358889
[TBL] [Abstract][Full Text] [Related]
44. Association Between Socioeconomic Status and Adherence to Fecal Occult Blood Tests in Colorectal Cancer Screening Programs: Systematic Review and Meta-Analysis of Observational Studies.
Luo Z; Dong X; Wang C; Cao W; Zheng Y; Wu Z; Xu Y; Zhao L; Wang F; Li J; Ren J; Shi J; Chen W; Li N
JMIR Public Health Surveill; 2023 Oct; 9():e48150. PubMed ID: 37906212
[TBL] [Abstract][Full Text] [Related]
45. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
46. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
Berger BM; Parton MA; Levin B
Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
[TBL] [Abstract][Full Text] [Related]
47. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø
Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic Performance of One-off Flexible Sigmoidoscopy with Fecal Immunochemical Testing in a Large Screening Population.
Niedermaier T; Weigl K; Hoffmeister M; Brenner H
Epidemiology; 2018 May; 29(3):397-406. PubMed ID: 29287053
[TBL] [Abstract][Full Text] [Related]
49. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
50. Sensitivity and specificity of CT colonography for the detection of colonic neoplasia after positive faecal occult blood testing: systematic review and meta-analysis.
Plumb AA; Halligan S; Pendsé DA; Taylor SA; Mallett S
Eur Radiol; 2014 May; 24(5):1049-58. PubMed ID: 24519111
[TBL] [Abstract][Full Text] [Related]
51. Barriers to completing colonoscopy after a positive fecal occult blood test.
Azulay R; Valinsky L; Hershkowitz F; Elran E; Lederman N; Kariv R; Braunstein B; Heymann A
Isr J Health Policy Res; 2021 Feb; 10(1):11. PubMed ID: 33573698
[TBL] [Abstract][Full Text] [Related]
52. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
53. Colorectal cancer screening: scientific review.
Walsh JM; Terdiman JP
JAMA; 2003 Mar; 289(10):1288-96. PubMed ID: 12633191
[TBL] [Abstract][Full Text] [Related]
54. Agreement between self-reported and registered colorectal cancer screening: a meta-analysis.
Dodou D; de Winter JC
Eur J Cancer Care (Engl); 2015 May; 24(3):286-98. PubMed ID: 24754544
[TBL] [Abstract][Full Text] [Related]
55. The impact of cumulative colorectal cancer screening delays: A simulation study.
Rutter CM; Inadomi JM; Maerzluft CE
J Med Screen; 2022 Jun; 29(2):92-98. PubMed ID: 34894841
[TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer screening.
Bretthauer M
J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
[TBL] [Abstract][Full Text] [Related]
57. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
O'Leary BA; Olynyk JK; Neville AM; Platell CF
J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
[TBL] [Abstract][Full Text] [Related]
58. The impact of stratifying by family history in colorectal cancer screening programs.
Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
[TBL] [Abstract][Full Text] [Related]
59. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies.
Castells A; Bessa X; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas A; Carballo F; Morillas JD; Hernández C; Jover R; Montalvo I; Arenas J; Cosme A; Hernández V; Iglesias B; Castro I; Cid L; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Roncales MP; González-Rubio F; Seoane-Urgorri A; Grau J; Serradesanferm A; Pellisé M; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; de la Vega-Prieto M; Iglesias R; Amador J; Blanco JM; Sastre R; Ferrándiz J; González-Hernández MJ; Andreu M;
J Natl Cancer Inst; 2013 Jun; 105(12):878-86. PubMed ID: 23708054
[TBL] [Abstract][Full Text] [Related]
60. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
